Your browser doesn't support javascript.
loading
The Microbiota-Gut-Brain Axis: Clinical Applications in Obesity and Type 2 Diabetes
Moser, Brandy; Milligan, Megan A.; Dao, Maria C..
Affiliation
  • Moser, Brandy; University of New Hampshire. Durham. US
  • Milligan, Megan A.; University of New Hampshire. Durham. US
  • Dao, Maria C.; University of New Hampshire. Durham. US
Rev. invest. clín ; 74(6): 302-313, Nov.-Dec. 2022. graf
Article in En | LILACS-Express | LILACS | ID: biblio-1431819
Responsible library: MX1.1
ABSTRACT
ABSTRACT Recent investigations highlight the importance of the gut microbiota and bacteria-derived metabolites as key components in obesity and metabolic health. The microbiota-gut-brain axis presents promising targets for future obesity treatments and prevention. However, the current state of evidence and existing clinical applications of the microbiota-gut-brain axis have yet to be summarized in a thorough review. Therefore, we sought to examine current evidence on the effect of lifestyle, dietary, pharmacological, and surgical interventions on the microbiota-gut-brain axis. In addition, this review highlights potential next steps in research toward characterizing the role of the microbiota-gut-brain axis in metabolic health, along with possible interventions to address obesity.
Key words

Full text: 1 Collection: 01-internacional Database: LILACS Language: En Journal: Rev. invest. clín Journal subject: MEDICINA Year: 2022 Document type: Article Affiliation country: United States Country of publication: Mexico

Full text: 1 Collection: 01-internacional Database: LILACS Language: En Journal: Rev. invest. clín Journal subject: MEDICINA Year: 2022 Document type: Article Affiliation country: United States Country of publication: Mexico